Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Foss

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Leukemia|June 25, 1998
Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cellsA Urbano, Y Koc, F M Foss
Bone Marrow Transplantation|June 1, 2002
Extracorporeal photopheresis in chronic graft-versus-host diseaseF M Foss, G Gorgun, K B Miller
Clinical Nuclear Medicine|March 1, 1997
Bone marrow suppression after strontium-89 therapy and local radiation therapy in patients with diffuse marrow involvementR A Powsner, A L Zietman, F M Foss
Journal of the American Academy of Dermatology|March 1, 1997
Proceedings of the International Consensus Conference on Cutaneous T-cell Lymphoma (CTCL) Treatment Recommendations. Boston, Massachusetts, Oct. 1 and 2, 1994M F Demierre, F M Foss, H K Koh
The American Journal of Medicine|June 1, 1983
Cerebrospinal fluid rhinorrhea as a complication of malignant lymphomaF M Foss, J Horneff, D L Longo, et al.
Oncogene Research|January 1, 1989
Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cellsF M Foss, A Veillette, O Sartor, et al.
Bioconjugate Chemistry|April 21, 1998
Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7: a novel agent for the elimination of IL-7 receptor positive cellsE B Sweeney, F M Foss, J R Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Neurotoxicity of purine analogs: a reviewB D Cheson, D A Vena, F M Foss, et al.
Oncogene Research|September 1, 1987
Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell linesA Veillette, F M Foss, E A Sausville, et al.
Clinical Lymphoma|November 15, 2001
Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedicationF M Foss, P Bacha, K E Osann, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Leukemia|June 25, 1998
Arginine butyrate downregulates p210 bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cellsA Urbano, Y Koc, F M Foss
Bone Marrow Transplantation|June 1, 2002
Extracorporeal photopheresis in chronic graft-versus-host diseaseF M Foss, G Gorgun, K B Miller
Clinical Nuclear Medicine|March 1, 1997
Bone marrow suppression after strontium-89 therapy and local radiation therapy in patients with diffuse marrow involvementR A Powsner, A L Zietman, F M Foss
Journal of the American Academy of Dermatology|March 1, 1997
Proceedings of the International Consensus Conference on Cutaneous T-cell Lymphoma (CTCL) Treatment Recommendations. Boston, Massachusetts, Oct. 1 and 2, 1994M F Demierre, F M Foss, H K Koh
The American Journal of Medicine|June 1, 1983
Cerebrospinal fluid rhinorrhea as a complication of malignant lymphomaF M Foss, J Horneff, D L Longo, et al.
Oncogene Research|January 1, 1989
Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cellsF M Foss, A Veillette, O Sartor, et al.
Bioconjugate Chemistry|April 21, 1998
Interleukin 7 (IL-7) receptor-specific cell killing by DAB389 IL-7: a novel agent for the elimination of IL-7 receptor positive cellsE B Sweeney, F M Foss, J R Murphy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Neurotoxicity of purine analogs: a reviewB D Cheson, D A Vena, F M Foss, et al.
Oncogene Research|September 1, 1987
Expression of the lck tyrosine kinase gene in human colon carcinoma and other non-lymphoid human tumor cell linesA Veillette, F M Foss, E A Sausville, et al.
Clinical Lymphoma|November 15, 2001
Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedicationF M Foss, P Bacha, K E Osann, et al.
Pageof 4